COVID-19 antibody drugs from Regeneron and Eli Lilly should no longer be used because they don’t work against the omicron variant, U.S. health officials said.
Source: ABC News 6
FDA halts use of monoclonal antibody drugs from Regeneron, Eli Lilly that don't work vs. omicron
Published in Robesonia
More from RobesoniaMore posts in Robesonia »
- Moscow court rejects Evan Gershkovich's appeal, keeping WSJ reporter in jail until at least June 30
- Senate takes up $95B foreign aid package for Ukraine, Israel and Taiwan
- 5 people hit by car in Northeast Philadelphia grocery store parking lot; driver detained
- Judge conducts hearing on request to hold Donald Trump in contempt for social media posts
- NBA playoffs: 76ers fall to Knicks 104-101 in Game 2
Be First to Comment